Homeopathic complex

a technology of complex and homeopathy, applied in the field of homeopathic complex, can solve the problems of inability to reconstitute a homeopathic mother tincture from a homeopathic mother tincture, the loss of chemical toxicity, and the inability to treat the disease with conventional treatment, so as to achieve the effect of treating or prophylaxis of infection

Inactive Publication Date: 2010-12-16
FARRINGTON DANIEL +1
View PDF5 Cites 31 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0212]As expanded on above in relation to Core A, an important aspect of the present invention is the potency of the homeopathic complex. Specifically, the homeopathic complex may be provided at different potency levels in order to work in different areas and on different conditions. Thus, changing the potency, by dilution and succession, will give a homeopathic complex with a different mode of action. Thus, a significant advantage of the present invention is that both the homeopathic ingredients of Cores A to D can be combined in different ways and the potency can be altered. Different combinations of Cores and different potencies will result in a homeopathic complex used for different conditions.
[0213]The invention will now be described in relation to specific embodiments of the invention and their end uses.
[0214]According to a one specific embodiment of the invention, there is provided a general anti-infective homeopathic composition comprising a homeopathic tincture or dilutions thereof of:
[0216]Aconite napellus; Arnica montana; Arsenicum iodatum; Belladonna; Bellis perennis; Bryonia alba; Calenula Offcinalis; Chamomilla Matricaria; Echinacea angustifolia; Echinacea purpurea; Graphites naturalis; Hamamelis virginiana; Hypericum Perforatum; Ledum palustre; Millefolium achillea; Phytolacca decandra; Rhus Toxicodendron; Ruta Graveolans; Stellaria media; Sulphur; Symphytum officinale; and Thuja Occidentalis.
[0217]Thus, the general anti-infective healing composition comprises a homeopathic tincture or dilutions thereof of Core A, Core B, Graphites, Sulphur, Thuja, Chamomilla and Stellaria.
[0218]Optional ingredients which may be included are Conium maculatum and / or Gunpowder (depending on Regulatory constraints).

Problems solved by technology

The process of dilution and succussion leads to a gradual loss of chemical toxicity while gradually increasing the homeopathic potency.
Additionally, it is important to note that it is not possible to reconstitute a herbal mother tincture from a homeopathic mother tincture.
Such conventional treatments can have major side-effects to the detriment of many internal organs.
Statins can also have severe side effect on the liver and kidney.
Rhabdomyolysis (the pathological breakdown of skeletal muscle) may lead to acute renal failure when muscle breakdown products damage the kidney.
Many other therapies for a wide range of conditions also result in side effects ranging from mild to potentially lethal side effects.
These side effects and other detrimental effects can also reduce patient compliance to the drug therapy.
Anti-anxiety drugs (anxiolytics) can have either a sedative side effect or other often more hidden behavioural effects can occur, such as dissociation or there may be a long term inability to cope without the drugs.
It has been recorded that drugs used for the purposes of sedation have in some cases resulted in the aggravation of symptoms such as aggression following their use.
ACP is frequently used in combination with other sedatives and anaesthetics to provide smoother sedation ACP can cause side effects, such as effects on blood pressure.
Due to these side-effects, it may not be possible to administer ACP to some animals.
Anti-pruritic drugs, which reduce pruritus, or itching, can have side effects such as drowsiness and lowering blood pressure.
Furthermore, another problem with current conventional methodologies is that no therapy is 100% effective across a population no matter what condition is targeted.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Homeopathic complex
  • Homeopathic complex
  • Homeopathic complex

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0419]Subject—Springer Spaniel Female neutered, age 5 years old on Day 0.

Condition / Symptoms of Subject

[0420]The patient presented with non-healing wound of what appeared to be a MRSA-type infection resulting from minor surgical wound as a result of elective surgery in the area of the stopper pad. The owner described the original wound as having been completely closed after surgery.[0421]The patient had an ulcerative skin lesion which had started after minor surgery and had gradually extended.[0422]There had been no response to repeatedly changed conventional antibiotics (Fuciderm®) or the antibiotic impregnated dressings used[0423]After using a number of conventional antibacterial therapeutics the owner had decided to try an alternative approach.

Treatment

[0424]On Day 0 the patient was taken off all oral conventional medication. A cream consisting of Core A and Core B with the addition Fucidin was applied by mixing a tube of Topical Ophthalmic Antibiotic FUCITHALMIC® Viscous Eye prop...

example 2

[0428]Subject—Feline male neutered of indeterminate age

Conditions / Symptoms of Subject

[0429]The subject originally presented as a post road traffic accident patient, with multiple traumatic skin injuries and multiple fractures of the left femur the latter were repaired by open reduction and intramedullary pining. The fracture site had to be partially re-broken as there was already cartilaginous callus repair with very mal-aligned bone fragments.

[0430]The subject was post shock. It was already in the healing phase of injury, but the wounds were still open and fresh. The bone fractures were attempting to heal out of alignment. The subject was initially unable to walk on the hind legs despite having one un-fractured leg. The musculature bones and wounds were all painful. The wounds were due to grazing probably from contact with a road surface and so friction burns as well as wounds, bruising and fractures were present.

Treatment

[0431]The fractures were treated by open reduction. Immediat...

example 3 (

Example 3(b)

[0444]Subject—Herd of male and female pigs less than 1 year of age

Conditions / Symptoms of Subject

[0445]Subjects were presented with acute severe photo-dermatitis after being left out on new pasture during a period of unbroken sunshine. The subjects presented much as a case of bad human sunburn would (FIG. 3a) with the whole patient having a bright red burning hot inflamed tender skin with crusting of the skin at the worst affected areas where there was deep cracking due to third degree burning. There were areas of peeling and scabbing of the affected skin.

Treatment

[0446]Due to success with previous cases in a range of other species a treatment with Core A and Core B combined was used. However, due to the number of animals a novel delivery method was required. Aloe Vera Veterinary Spray (Forever Living Products) was used as a carrier for Core A and Core B. Once daily spraying of the carrier with Core A and Core B was decided upon with a second spray when possible at feedin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
body weightaaaaaaaaaa
timeaaaaaaaaaa
timeaaaaaaaaaa
Login to view more

Abstract

The present invention is directed to a homeopathic complex for use in the treatment of various diseases or disorders, including use as an anti-infective agent and / or in the regeneration of diseased or damaged tissue. Ideally, the anti-infective homeopathic complex of the invention may comprise a homeopathic tincture or dilutions thereof of Hepar sulphuris calcareum or other similar profiled Calcarea or Sulphur salt or acid, Lachesis muta or other remedy with a similar profile, Mercurius Solubilis or similar mercury containing remedy and Silica or other silica containing compounds.

Description

INCORPORATION BY REFERENCE[0001]This application is a continuation-in-part application of international patent application Serial No. PCT / EP2008 / 008602 filed 10 Oct. 2008, which published as PCT Publication No. WO 2009 / 047005 on 16 Apr. 2009, which claims benefit of Irish patent application Serial No. 2007 / 0737 filed 10 Oct. 2007.[0002]The foregoing applications, and all documents cited therein or during their prosecution (“appln cited documents”) and all documents cited or referenced in the appln cited documents, and all documents cited or referenced herein (“herein cited documents”), and all documents cited or referenced in herein cited documents, together with any manufacturer's instructions, descriptions, product specifications, and product sheets for any products mentioned herein or in any document incorporated by reference herein, are hereby incorporated herein by reference, and may be employed in the practice of the invention.FIELD OF THE INVENTION[0003]The present invention ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K36/00C07F7/02A61P31/00A61K35/02A61K35/58A61K35/646
CPCA61K33/00A61K33/04A61K33/06A61K33/28A61K35/02A61K35/58A61K35/583A61K36/185A61K41/0004A61K45/06A61K35/646A61K2300/00A61P31/00
Inventor FARRINGTON, DANIELFARRINGTON, THOMAS
Owner FARRINGTON DANIEL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap